Crown Equity Holdings Inc. is publicly traded with the symbol CRWE. The Company primarily provides and offers advertising, branding, marketing solutions and services to boost customer awareness, as well as merchant visibility as a worldwide online multi-media publisher. For list of services offered click here

Change City

On 28 June 2016, the Energy Charter Secretary General Urban Rusnák attended the second day of 2016 Asia Energy Cooperation Forum in Chongqing, China and delivered a speech on the relevance of the Energy Charter and its principles, particularly within the context of China’s "One Belt One Road Initiative". During the Forum, three other Chinese speakers also dedicated their presentations exploring various aspects, contexts, and potential benefits of deeper Chinese involvement within the Energy Charter Process. Additionally, the Forum participants also approved the "Chongqing Understanding" on Asian energy cooperation that also includes inputs and references to the Energy Charter. The Forum is co-organised by the Chinese Ministry of Foreign Affairs, the National Energy Administration and the China Institute of International Affairs. The Secretary General will also attend the G20 Energy Ministerial Meeting and the Global Forum on Energy Security in Beijing later this week.

Energy Charter News

The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.

Quest Diagnostics Inc. (NYSE:DGX) offers the most extensive clinical testing network in the U.S. The Company's extensive test menu includes routine biological testing; complex and specialized molecular and gene-based testing, and anatomic pathology testing. These services primarily help identify disease or risk factors for disease and predict and monitor response to treatment.

Quest Diagnostics Inc. (NYSE:DGX) offers the most extensive clinical testing network in the U.S. The Company's extensive test menu includes routine biological testing; complex and specialized molecular and gene-based testing, and anatomic pathology testing. These services primarily help identify disease or risk factors for disease and predict and monitor response to treatment.